New drugs developed in-house won't contribute 16 cents to 2012 earnings per share. They won't even account for six cents.
If in ten years PFE has barely been able to generate sales of a billion dollars from in-house R&D products, how on earth can the company possibly achieve revenues of some four billion dollars from new intros in just two years?
You're insane & a fool soon parted from his money.
No wonder you've lost such a gigantic share of your inheritance so quickly.